Johnson & Johnson

Johnson & Johnson is an American multinational corporation specializing in pharmaceutical, biotechnology, and medical technologies. Founded in 1886, the company's mission is to improve human health and well-being globally, focusing on enhancing access, affordability, and fostering healthier communities. Its world headquarters are located in New Brunswick, New Jersey, U.S.

Following the spin-off of its consumer health business (Kenvue) in 2023, Johnson & Johnson now primarily operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment develops treatments across therapeutic areas such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism. The MedTech segment focuses on interventional solutions, orthopedics, surgery, and vision care technologies.

Led by Chairman and CEO Joaquin Duato, Johnson & Johnson maintains a strong market position as one of the world's most valuable companies, holding a prime credit rating of AAA. The company was ranked No. 48 on the 2025 Fortune 500 list and 42nd in the 2025 Forbes Global 2000. Recent strategic moves include significant acquisitions, such as Shockwave Medical in 2025 and Abiomed in 2022, reinforcing its focus on high-growth areas like oncology and cardiovascular technology. Johnson & Johnson continues to emphasize a robust pipeline and aims to be the leading oncology company by 2030.